MarketScreener Homepage > Equities > Tokyo Stock Exchange > FUJIFILM Holdings Corporation 4901 JP3814000000

Report

End-of-day quote Tokyo Stock Exchange - 01/21
6188	JPY		+0.42%

01/06

FUJIFILM : says will invest $2 billion in new large-scale cell culture production site in U.S

2020

DR REDDY LABORATORIES : . Reddy's Lab's Canadian Unit Seeks Health Canada's Approval for COVID-19 ug

2020

APPILI THERAPEUTICS : Appli Therapeutics Up 3% As Consortium Files Application for Reeqonus to Treat COVID-19 Under Health Canada Interim Order

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote Tokyo Stock Exchange

01/15/2021	01/18/2021	01/19/2021	01/20/2021	01/21/2021	Date
6132	6094	6171	6162	6188	Last
1741600	1124200	1784100	1384100	1848300	Volume
0.00%	-0.62%	+1.26%	-0.15%	+0.42%	Change

Financials

Sales 2021	2 185 B 21 054 M 21 054 M
Net income 2021	132 B 1 271 M 1 271 M
Net Debt 2021	202 B 1 948 M 1 948 M
P/E ratio 2021	18,7x
Yield 2021	1,55%

Sales 2022	2 341 B 22 560 M 22 560 M
Net income 2022	149 B 1 433 M 1 433 M
Net Debt 2022	182 B 1 758 M 1 758 M
P/E ratio 2022	16,4x
Yield 2022	1,63%

Capitalization	2 474 B 23 892 M 23 842 M
EV / Sales 2021	1,22x
EV / Sales 2022	1,13x
Nbr of Employees	73 906
Free-Float	73,9%

More Financials

Company

Fujifilm Holdings Corporation specializes in the manufacturing and marketing of printing, imaging and photography materials and equipment. Net sales break down by activity as follows: - sale of printers and photocopiers (42.7%); - sale of medical imaging equipment (41.4%): digital endoscopes, digital mammography devices, radiologic tables, ultrasound scan systems, etc. The group also develops pharmaceutical...

Sector

Office Equipment

Calendar

02/09 | 07:00am

Ergebnisveröffentlichung

More about the company

Notations Surperformance© of FUJIFILM Holdings Corporation

Trading Rating :

Investor Rating :

More Ratings

All news about FUJIFILM HOLDINGS CORPORATION

01/06	FUJIFILM : says will invest $2 billion in new large-scale cell culture productio..	RE
2020	DR REDDY LABORATORIES : . Reddy's Lab's Canadian Unit Seeks Health Canada's Appr..	MT
2020	APPILI THERAPEUTICS : Appli Therapeutics Up 3% As Consortium Files Application f..	MT
2020	DR REDDY LABORATORIES : . Reddy's Files Application in Canada for COVID-19 Treat..	MT
2020	Nikkei hits 3-week low as new virus strain damps recovery hopes	RE
2020	Japanese shares drop as new virus strain sparks profit-taking	RE
2020	CORRECTION ( : Vietnam-Fujifilm:)	AQ
2020	FUJIFILM : Japan's Fujifilm to make coronavirus antigen testing kits in Vietnam	AQ
2020	Japan review of Avigan says efficacy for COVID-19 treatment inconclusive -Kyo..	RE
2020	SYNTHETICMR : product to be available in Fujifilm's Synapse PACS solution to cus..	AQ
2020	Appili Therapeutics Says First Patient Dosed in Phase 3 Clinical Trial of Tab..	MT
2020	FUJIFILM : Cellular Dynamics and Lonza Agree to Expand the Availability and Use ..	AQ
2020	Lonza, FUJIFILM Cellular Dynamics Collaborate on Cell Technologies	MT
2020	Fujifilm's Fiscal H1 Profit Up 11%, Revenue Slides 12%	MT
2020	FUJIFILM HOLDINGS CORPORATION : Half-year results	CO

More news

News in other languages on FUJIFILM HOLDINGS CORPORATION

01/07	PLANÈTE BOURSE : La revue de presse du jeudi 7 janvier 2021
2020	TOKYO STOCK EXCHANGE : Borsa Tokyo a minimi 3 settimane, variante virus smorza s..
2020	Les Bourses asiatiques victimes des craintes liées au coronavirus mutant
2020	Tokyo ouvre en baisse, la pandémie pèse toujours
2020	Vent d'optimisme sur les Bourses asiatiques, l'oeil rivé sur le Congrès US

More news

Provided by Scoopnest.com

Analysis

Fujifilm : says will invest $2 billion in new large-scale cell culture production site in U.S

More Must read

Chart FUJIFILM HOLDINGS CORPORATION

Duration : Period :

FUJIFILM Holdings Corporation Technical Analysis Chart | 4901 | JP3814000000 | MarketScreener

Full-screen chart

Technical analysis trends FUJIFILM HOLDINGS CORPORATION

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	BUY
Number of Analysts	16
Average target price	6 793,33 JPY
Last Close Price	6 188,00 JPY
Spread / Highest target	61,6%
Spread / Average Target	9,78%
Spread / Lowest Target	-14,4%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Shigetaka Komori	Chairman & Group Chief Executive Officer
Kenji Sukeno	President, Group COO & Representative Director
Takashi Iwasaki	Director & Chief Technology Officer
Kouichi Tamai	Director & Vice President
Takatoshi Ishikawa	Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

FUJIFILM HOLDINGS CORPORATION	13.79%	23 892



CANON INC.	12.56%	22 488
BROTHER INDUSTRIES, LTD.	10.54%	5 898
RICOH COMPANY, LTD.	9.16%	5 170
KONICA MINOLTA, INC.	7.87%	2 034
TOSHIBA TEC CORPORATION	1.48%	2 008

More Results